An audit of people with epilepsy, aged 16–55 years, taking valproate in UK primary care in 2023–4

IF 2.7 3区 医学 Q2 CLINICAL NEUROLOGY
I Minshall , A Neligan
{"title":"An audit of people with epilepsy, aged 16–55 years, taking valproate in UK primary care in 2023–4","authors":"I Minshall ,&nbsp;A Neligan","doi":"10.1016/j.seizure.2025.02.008","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>To audit the standard of clinical care of people with epilepsy (PWE), aged 16–55 years, taking valproate attending UK general practice.</div></div><div><h3>Method</h3><div>The case notes of 213 PWE (44 women, 169 men) were audited against standards based on National Institute for Health and Care Excellence (NICE), Drug Safety Unit (DSU) and Medicines and Healthcare products Regulatory Agency (MHRA) guidelines.</div></div><div><h3>Results</h3><div>For PWE taking valproate annual review rates in General Practice (GP) were consistently sub-standard, with an average of 42 % for women and 31 % of men in the last 5 years. Fifty percent of men had seen no clinician in 2023 concerning their epilepsy, compared with 23 % women (<em>p</em> = 0.0013). Generalised onset epilepsy was diagnosed in 75 % women and 63 % men. A range of medication was used as add on therapy, with lamotrigine, levetiracetam, and clobazam being most often used. Sixty eight percent of women were actively engaged with the valproate pregnancy prevention program (Valproate PPP); a further 21 % had clear clinical reasons where potential pregnancy was not an issue (history of hysterectomy, severe learning disability) whilst the remaining 11 % of those who should have been engaged with the Valproate PPP were not. Four men had received pre-conceptual counselling. Exposure to valproate for more than 10 years was present in 80 % women and 73 % men. Fifty percent of women and 42 % men were receiving vitamin D supplementation. Eighteen (8 %) people had a bone density scan, 39 % of which were abnormal.</div></div><div><h3>Conclusion</h3><div>The standard of care of PWE taking valproate in primary care is concerning, with poor yearly review rates, especially for men. Engagement with the Valproate PPP was absent in 11 % of women, who should have been engaged with this. Long exposure and the lack of vitamin D supplementation needs attention. The re-introduction of the Quality and Outcomes Framework (QOF) for epilepsy with defined clinical targets could potentially address the needs identified.</div></div>","PeriodicalId":49552,"journal":{"name":"Seizure-European Journal of Epilepsy","volume":"127 ","pages":"Pages 1-6"},"PeriodicalIF":2.7000,"publicationDate":"2025-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seizure-European Journal of Epilepsy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1059131125000391","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose

To audit the standard of clinical care of people with epilepsy (PWE), aged 16–55 years, taking valproate attending UK general practice.

Method

The case notes of 213 PWE (44 women, 169 men) were audited against standards based on National Institute for Health and Care Excellence (NICE), Drug Safety Unit (DSU) and Medicines and Healthcare products Regulatory Agency (MHRA) guidelines.

Results

For PWE taking valproate annual review rates in General Practice (GP) were consistently sub-standard, with an average of 42 % for women and 31 % of men in the last 5 years. Fifty percent of men had seen no clinician in 2023 concerning their epilepsy, compared with 23 % women (p = 0.0013). Generalised onset epilepsy was diagnosed in 75 % women and 63 % men. A range of medication was used as add on therapy, with lamotrigine, levetiracetam, and clobazam being most often used. Sixty eight percent of women were actively engaged with the valproate pregnancy prevention program (Valproate PPP); a further 21 % had clear clinical reasons where potential pregnancy was not an issue (history of hysterectomy, severe learning disability) whilst the remaining 11 % of those who should have been engaged with the Valproate PPP were not. Four men had received pre-conceptual counselling. Exposure to valproate for more than 10 years was present in 80 % women and 73 % men. Fifty percent of women and 42 % men were receiving vitamin D supplementation. Eighteen (8 %) people had a bone density scan, 39 % of which were abnormal.

Conclusion

The standard of care of PWE taking valproate in primary care is concerning, with poor yearly review rates, especially for men. Engagement with the Valproate PPP was absent in 11 % of women, who should have been engaged with this. Long exposure and the lack of vitamin D supplementation needs attention. The re-introduction of the Quality and Outcomes Framework (QOF) for epilepsy with defined clinical targets could potentially address the needs identified.

Abstract Image

求助全文
约1分钟内获得全文 求助全文
来源期刊
Seizure-European Journal of Epilepsy
Seizure-European Journal of Epilepsy 医学-临床神经学
CiteScore
5.60
自引率
6.70%
发文量
231
审稿时长
34 days
期刊介绍: Seizure - European Journal of Epilepsy is an international journal owned by Epilepsy Action (the largest member led epilepsy organisation in the UK). It provides a forum for papers on all topics related to epilepsy and seizure disorders.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信